International Myeloma Foundation

MYELOMA MINUTE | Up To The Minute News | 12.16.2021

Tips for Building and Maintaining Our Resilience in the New Year

Small actions can make a big difference in our well-being, says IMF Chairman Dr. Brian G.M. Durie. He recommends small doses of exercise, meditation and, of course, silly videos for nourishing our resilience as we head into 2022.

Don’t Miss the Best of ASH 2021 Webinar Today!

Today at 4 p.m. PST; 5 p.m. MT; 6 p.m. CT; and 7 p.m. EST, Dr. Brian G.M. Durie will discuss important takeaways relating to multiple myeloma from this year’s American Society of Hematology (ASH) conference. Get to know the highlights of the top myeloma abstracts that were presented at the ASH annual conference in this “Best of ASH 2021” webinar.

Support Group Leaders Attended the 2021 ASH Meeting. Read Their Blogs.

The International Myeloma Foundation (IMF) brought together myeloma support group leaders and patients to this year’s virtual 63rd Annual Meeting and Exposition of the American Society of Hematology (ASH). The 63rd ASH meeting was an exciting convergence of 20,000 healthcare professionals from across the globe. Read through the IMF ASH team members’ accounts of the event via their blogs.

Watch the Replay: The IMWG Conference Series

Watch the replay of this lively discussion on the forefront of the future of myeloma research and care — moderated by IMF Chairman of the Board Dr. Brian G.M. Durie. Leading myeloma experts discuss the latest drug therapy from ASH 2021, and focus on other highlights from the 879 multiple-myeloma-related abstracts from the ASH conference this year.

Shop for a Cause with this Member FUNraiser: Laurie’s Winter Hat Boutique

Explore and shop at Laurie’s Winter Hat Boutique for hand-knit hats to keep you warm during these chilly winter days and to raise money for a cause! All proceeds will go to myeloma research with the International Myeloma Foundation.

#ASKDRDURIE | Dr. Durie's Weekly Web Video Series

This Week’s Question:

Are MGUS patients at higher risk of getting severely ill from COVID-19?

Online Patient Forum

Smart Patients: Join the Conversation

Clinical Trial Fact Sheets

CANOVA Trial (Accruing)

Phase II Relapsed or Refractory Venetoclax Trial (Accruing)

Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib (Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Ongoing Replays

Watch the Replay
IMWG Conference Series: ASH 2021

Watch the Replay
Advances in Myeloma Treatments Webinar

Watch the Replay
COVID-19 and Myeloma Webinar

Watch the Replay
Regional Community Workshop

See also, all of our events.

We Thank Our Sponsors:

Amgen, Bristol Myers Squibb, GSK, Karyopharm Therapeutics, Oncopeptides Inc.,
Sanofi-Genzyme, and Takeda Oncology

We also thank individuals like you for your continued support!

Join the conversation at The International Myeloma Foundation

Facebook: /Myeloma |

Twitter @IMFMyeloma |

Instagram @IMFmyeloma

www.myeloma.org

This email was sent by:
The International Myeloma Foundation
4400 Coldwater Canyon Ave., Suite 300
Studio City, CA 91604
Connect with the IMF InfoLine
1-800-452-2873

We respect your privacy and your preferences for communications of this nature.
Home • Unsubscribe • Privacy Policy

View as web page

nonprofit software

Pen	Mug	T-Shirt (please contact us to specify size: S, M, L, XL, or XXL)
Canteen	Plush Microfiber Blanket

Hope Society Membership Benefits

Limited Edition Hope Society Gifts